Search Results - "Kiferle, L"

Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study by Rossi, C., Frosini, D., Volterrani, D., De Feo, P., Unti, E., Nicoletti, V., Kiferle, L., Bonuccelli, U., Ceravolo, R.

“…Introduction:  In idiopathic Parkinson’s disease (PD), two different clinical phenotypes are usually distinguished: a tremor dominant variant (TD) and an…”
Get full text

Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction by Ceravolo, R., Frosini, D., Poletti, M., Kiferle, L., Pagni, C., Mazzucchi, S., Volterrani, D., Bonuccelli, U.

“…Background and purpose The investigation of the relationship between affective symptoms and dopamine transporter (DAT) density provided conflicting data in…”
Get full text

Positron emission tomography imaging in multiple sclerosis-current status and future applications by Kiferle, L., Politis, M., Muraro, P. A., Piccini, P.

“…Background:  Multiple Sclerosis (MS) is traditionally considered as a central nervous system (CNS) white matter inflammatory disease. However, recent studies…”
Get full text

CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease by Ceravolo, R, Borghetti, D, Kiferle, L, Tognoni, G, Giorgetti, A, Neglia, D, Sassi, N, Frosini, D, Rossi, C, Petrozzi, L, Siciliano, G, Murri, L

“…Abstract One major goal of drug development would be the establishment of biomarkers as objective indicators of normal biological and pathogenetic processes,…”
Get full text

1.095 METABOLIC CHANGES INDUCED BY THETA BURST STIMULATION OF THE CEREBELLUM IN DYSKINETIC PARKINSON'S DISEASE PATIENTS by Koch, G, Brusa, L, Ceravolo, R, Kiferle, L, Schillaci, O, Stanzione, P

Get full text

Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers by Ceravolo, R, Antonini, A, Volterrani, D, Rossi, C, Goldwurm, S, Di Maria, E, Kiferle, L, Bonuccelli, U, Murri, L

“…The authors studied four patients with parkinsonism carrying the fragile X premutation using SPECT with ([23)I]FP-CIT. They found evidence of preserved…”
Get full text

Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia by Ceravolo, R, Volterrani, D, Frosini, D, Bernardini, S, Rossi, C, Logi, C, Manca, G, Kiferle, L, Mariani, G, Murri, L, Bonuccelli, U

“…Several evidences suggest that cholinergic deficits may significantly contribute to dementia in Parkinson's disease (PDD) and acetylcholinesterase inhibitors…”
Get full text

Environmental factors and Parkinson's disease: a case–control study in the Tuscany region of Italy by Nuti, A., Ceravolo, R., Dell'Agnello, G., Gambaccini, G., Bellini, G., Kiferle, L., Rossi, C., Logi, C., Bonuccelli, U.

“…To date the aetiology of Parkinson's disease (PD) is unknown although both genetic susceptibility and environmental factors appear to play an important role in…”
Get full text

D06Platelet Bdnf In Huntington's Disease: Evidence From A Preliminary Study by Mazzucchi, S, Unti, E, Kiferle, L, Palego, L, Giannaccini, G, Lucacchini, A, Bonuccelli, U, Ceravolo, R

“…BackgroundBrain Derived Neurotrophic Factor (BDNF) is a neurotrophin implicated in the pathogenesis of neurodegenerative diseases and mood disorders; highly…”
Get full text

D06 Platelet Bdnf In Huntington's Disease: Evidence From A Preliminary Study by Mazzucchi, S., Unti, E., Kiferle, L., Palego, L., Giannaccini, G., Lucacchini, A., Bonuccelli, U., Ceravolo, R.

Get full text

Q09 Valproic Acid for the treatment of aggressiveness in Huntington's disease: 1-year follow-up by Unti, E, Mazzucchi, S, Kiferle, L, Bonuccelli, U, Ceravolo, R

“…BackgroundHuntington's disease (HD) is characterised by involuntary movements, cognitive decline and psychiatric symptoms such as aggressiveness, and…”
Get full text

Q09Valproic Acid for the treatment of aggressiveness in Huntington's disease: 1-year follow-up by Unti, E, Mazzucchi, S, Kiferle, L, Bonuccelli, U, Ceravolo, R

“…BackgroundHuntington's disease (HD) is characterised by involuntary movements, cognitive decline and psychiatric symptoms such as aggressiveness, and…”
Get full text

Mild affective symptoms in de novo P arkinson's disease patients: relationship with dopaminergic dysfunction by Ceravolo, R., Frosini, D., Poletti, M., Kiferle, L., Pagni, C., Mazzucchi, S., Volterrani, D., Bonuccelli, U.

“…Background and purpose The investigation of the relationship between affective symptoms and dopamine transporter ( DAT ) density provided conflicting data in…”
Get full text

I10 In vivo evidence of decreased nigrostriatal terminals in Huntington's disease: a SPECT study by Kiferle, L, Unti, E, Volterrani, D, De Feo, P, Rossi, C, Nicoletti, V, Bonuccelli, U, Ceravolo, R

“…Background Huntington's disease (HD) is pathologically characterised by a selective neurodegeneration of vulnerable populations of neurons, with an early…”
Get full text

Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease by Ceravolo, Roberto, Volterrani, Duccio, Tognoni, Gloria, Dell'Agnello, Grazia, Manca, Gianpiero, Kiferle, Lorenzo, Rossi, Carlo, Logi, Chiara, Strauss, H William, Mariani, Giuliano, Murri, Luigi

“…Cholinesterase (ChE) inhibitors improve or stabilize cognitive impairment in patients with Alzheimer disease (AD). However, the regional metabolic and…”
Get full text

HIGH Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers by CERAVOLO, R, ANTONINI, A, VOLTERRANI, D, ROSSI, C, GOLDWURM, S, DI MARIA, E, KIFERLE, L, BONUCCELLI, U, MURRI, L

Get full text